Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	motile cilium	SPAG4 CFAP251 DNAH10 SAXO2 WDR19 VPS13A CATSPERB CFAP69	3.28e-04	355	101	8	GO:0031514
GeneOntologyCellularComponent	THO complex	THOC3 THOC2	3.42e-04	6	101	2	GO:0000347
GeneOntologyCellularComponent	THO complex part of transcription export complex	THOC3 THOC2	3.42e-04	6	101	2	GO:0000445
GeneOntologyCellularComponent	adherens junction	XIRP1 SHROOM3 PARD3B FAT2 HMCN1 PLEKHA7	5.77e-04	212	101	6	GO:0005912
MousePheno	abnormal palatal shelf morphology	PDS5B SOX11 GSK3B WDR19 VANGL2 TGFBR3 PAX9 IHH	7.54e-07	121	86	8	MP:0031460
MousePheno	abnormal secondary palate development	PDS5B SOX11 GSK3B WDR19 VANGL2 TGFBR3 PAX9 IHH	9.09e-07	124	86	8	MP:0009655
MousePheno	abnormal palate development	PDS5B SOX11 GSK3B WDR19 VANGL2 TGFBR3 PAX9 IHH	1.23e-06	129	86	8	MP:0009653
MousePheno	abnormal sternum ossification	PDS5B SOX11 GSK3B WDR19 VANGL2	2.93e-06	37	86	5	MP:0008277
MousePheno	abnormal endochondral bone ossification	PDS5B SOX11 GSK3B WDR19 VANGL2 XYLT1 IHH	4.40e-06	108	86	7	MP:0008272
MousePheno	abnormal palatal shelf fusion at midline	PDS5B SOX11 GSK3B WDR19 TGFBR3 PAX9	9.49e-06	80	86	6	MP:0009887
MousePheno	abnormal bone ossification	PDS5B SOX11 GC GSK3B MEPE WDR19 VANGL2 XYLT1 TGFBR3 IHH NOS3	2.91e-05	395	86	11	MP:0008271
MousePheno	ventricular septal defect	PDS5B SOX11 SHROOM3 VANGL2 TGFBR3 VCAN PAX9 NOS3 BICC1	3.15e-05	261	86	9	MP:0010402
MousePheno	lethality during fetal growth through weaning, complete penetrance	CYLD PDS5B SOX11 SHROOM3 ILF3 CIT GSK3B WDR19 VANGL2 GMNC TGFBR3 KMT2C VCAN ASS1 PAX9 CAMTA1 IHH L3MBTL3 MUSK BICC1	6.70e-05	1269	86	20	MP:0011111
MousePheno	abnormal pectoral girdle bone morphology	PDS5B SOX11 VPS33A GSK3B WDR19 VANGL2 TGFBR3 AASS IHH	9.50e-05	301	86	9	MP:0004508
MousePheno	perinatal lethality, complete penetrance	CYLD PDS5B SOX11 SHROOM3 ILF3 GSK3B VANGL2 KMT2C VCAN ASS1 PAX9 IHH L3MBTL3 MUSK	1.04e-04	712	86	14	MP:0011089
MousePheno	abnormal sternum morphology	PDS5B SOX11 VPS33A GSK3B WDR19 VANGL2 TGFBR3 AASS	1.71e-04	255	86	8	MP:0000157
MousePheno	abnormal palatal shelf bone ossification	TGFBR3 IHH	2.23e-04	4	86	2	MP:0021217
MousePheno	abnormal interventricular septum morphology	PDS5B SOX11 SHROOM3 VANGL2 TGFBR3 VCAN PAX9 NOS3 BICC1	2.48e-04	342	86	9	MP:0000281
MousePheno	palatal shelves fail to meet at midline	PDS5B SOX11 GSK3B PAX9	3.59e-04	55	86	4	MP:0009888
MousePheno	decreased cortical ventricular zone thickness	SOX11 THOC2	3.70e-04	5	86	2	MP:0014558
MousePheno	abnormal male reproductive system physiology	SPAG4 DNAH10 PI4K2A SMPD4 SPAG9 TLR6 CIT VANGL2 TBCCD1 GMNC PPARGC1A KMT2C RESF1 MEIOC VPS13A PLEKHA1 CFAP69 NOS3 WDR48	3.75e-04	1329	86	19	MP:0003698
MousePheno	cleft palate	PDS5B SOX11 GSK3B WDR19 VANGL2 TGFBR3 PAX9 IHH	3.98e-04	289	86	8	MP:0000111
MousePheno	oral cleft	PDS5B SOX11 GSK3B WDR19 VANGL2 TGFBR3 PAX9 IHH	4.17e-04	291	86	8	MP:0021164
MousePheno	perinatal lethality	CYLD PDS5B SOX11 SHROOM3 ILF3 GSK3B VANGL2 PIAS4 KMT2C VCAN ASS1 PAX9 IHH L3MBTL3 NOS3 MUSK BICC1	4.52e-04	1130	86	17	MP:0002081
MousePheno	cyanosis	CYLD PDS5B SOX11 ILF3 VCAN NOS3 MUSK	4.79e-04	226	86	7	MP:0001575
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CASP8AP2 SHROOM3 SMPD4 ERI2 CEMIP2 WDR19 VANGL2 KMT2C UBE2O ZNF592 EIF2AK4 L3MBTL3 CNOT1 WNK2	5.97e-10	529	103	14	14621295
Pubmed	Human transcription factor protein interaction networks.	CYLD RARS1 ERG DNAH10 ATAD5 TNPO2 ACO2 SPAG9 CIT DDOST KMT2C UBE2O RESF1 ZNF592 MRPS11 PAX9 L3MBTL3 CNOT1 MYBL2 WDR48	6.57e-09	1429	103	20	35140242
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CACNB2 SHROOM3 KIZ PARD3B CCNY SNAP29 PIAS4 KMT2C SHC2 FAM120C TBC1D1 TBCK ASS1 EIF2AK4 LIMCH1 CAMTA1 CFAP69 CNOT1 WNK2	7.11e-08	1489	103	19	28611215
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CYLD SHROOM3 PARD3B NHSL1 PLEKHG1 RESF1 AASS TBC1D1 ASS1 PLEKHA1 LIMCH1 PLEKHA7 MUSK BICC1	2.62e-07	861	103	14	36931259
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CYLD SHROOM3 KIZ PARD3B CORO1B LRP1B PHAF1 PLEKHG1 MEIOC AASS TBC1D1 PLEKHA7 CNOT1	1.49e-06	853	103	13	28718761
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	PDS5B GC THOC3 KMT2C ZNF592 ASS1 EIF2AK4 LIMCH1 CNOT1 ANO3	2.34e-06	497	103	10	36774506
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ATAD5 SMPD4 SPAG9 DDOST GSK3B CEMIP2 NHSL1 VPS13A PLEKHA1 EIF2AK4 PLEKHA7 L3MBTL3 CNOT1 WDR48	2.69e-06	1049	103	14	27880917
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	RARS1 SYTL2 THOC2 KMT2C VPS13A EIF2AK4 CNOT1	3.02e-06	208	103	7	33230847
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CYLD CACNB2 THOC2 SNAP29 TBCCD1 PPARGC1A KMT2C RESF1 VCAN EIF2AK4 CAMTA1 PLEKHA7 CNOT1 BICC1	3.92e-06	1084	103	14	11544199
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CYLD CASP8AP2 SPAG9 KMT2C TBC1D1 CAMTA1 WDR48	5.05e-06	225	103	7	12168954
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	CASP8AP2 SMPD4 MAP10 CEMIP2 NHSL1 EIF2AK4	6.61e-06	153	103	6	10718198
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CYLD RARS1 ACO2 VPS33A CORO1B CIT LRP1B SNAP29 VANGL2 NHSL1 UBE2O FAM120C CNOT1 WNK2	6.89e-06	1139	103	14	36417873
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CYLD SHROOM3 THOC2 PLEKHG1 TBC1D1 ASS1 PLEKHA1 PLEKHA7 CNOT1	7.49e-06	446	103	9	24255178
Pubmed	Translational study of the whole transcriptome in rats and genetic polymorphisms in humans identifies LRP1B and VPS13A as key genes involved in tolerance to cocaine-induced motor disturbances.	LRP1B VPS13A	8.69e-06	2	103	2	33159041
Pubmed	Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha.	PPARGC1A NOS3	8.69e-06	2	103	2	16891621
Pubmed	PGC1 alpha coactivates ERG fusion to drive antioxidant target genes under metabolic stress.	ERG PPARGC1A	8.69e-06	2	103	2	35508713
Pubmed	Down-regulation of betatrophin enhances insulin sensitivity in type 2 diabetes mellitus through activation of the GSK-3β/PGC-1α signaling pathway.	GSK3B PPARGC1A	8.69e-06	2	103	2	33464548
Pubmed	Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma.	GSK3B PCDH9	8.69e-06	2	103	2	25172662
Pubmed	PGC-1α ameliorates AngiotensinII-induced eNOS dysfunction in human aortic endothelial cells.	PPARGC1A NOS3	8.69e-06	2	103	2	27235860
Pubmed	PGC-1α dictates endothelial function through regulation of eNOS expression.	PPARGC1A NOS3	8.69e-06	2	103	2	27910955
Pubmed	Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.	GSK3B VCAN	8.69e-06	2	103	2	22096483
Pubmed	A single bout of whole-leg, peristaltic pulse external pneumatic compression upregulates PGC-1α mRNA and endothelial nitric oxide sythase protein in human skeletal muscle tissue.	PPARGC1A NOS3	8.69e-06	2	103	2	25982469
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	RARS1 POLA1 TNPO2 SPAG9 DDOST KMT2C ZNF592 FAM120C VPS13A PWWP3B CNOT1	1.21e-05	736	103	11	29676528
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SMPD4 VANGL2 UBE2O MEIOC PLEKHA1 PLEKHA7 CNOT1	1.39e-05	263	103	7	34702444
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PDS5B ILF3 ERG PI4K2A SPAG9 THOC2 GSK3B CCNY ZNF592 LIMCH1 MYBL2	1.92e-05	774	103	11	15302935
Pubmed	SOXC Transcription Factors Induce Cartilage Growth Plate Formation in Mouse Embryos by Promoting Noncanonical WNT Signaling.	SOX11 VANGL2 IHH	1.99e-05	18	103	3	25761772
Pubmed	Mitotic WNT signalling orchestrates neurogenesis in the developing neocortex.	SOX11 GSK3B CCNY	2.36e-05	19	103	3	34431536
Pubmed	SCFCdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis.	GSK3B PPARGC1A	2.60e-05	3	103	2	18198341
Pubmed	Genome-wide association study of major recurrent depression in the U.K. population.	VCAN BICC1	2.60e-05	3	103	2	20516156
Pubmed	ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation.	ERG GSK3B	2.60e-05	3	103	2	35259458
Pubmed	Gene-environment interaction in chronic kidney disease among people with type 2 diabetes from The Malaysian Cohort project: a case-control study.	PPARGC1A NOS3	2.60e-05	3	103	2	32012348
Pubmed	Exercise training boosts eNOS-dependent mitochondrial biogenesis in mouse heart: role in adaptation of glucose metabolism.	PPARGC1A NOS3	2.60e-05	3	103	2	24381004
Pubmed	Genetic variations in CYP17A1, CACNB2 and PLEKHA7 are associated with blood pressure and/or hypertension in She ethnic minority of China.	CACNB2 PLEKHA7	2.60e-05	3	103	2	21963141
Pubmed	ATAD5 suppresses centrosome over-duplication by regulating UAF1 and ID1.	ATAD5 WDR48	2.60e-05	3	103	2	32594826
Pubmed	Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.	DNAH10 L3MBTL3	2.60e-05	3	103	2	27841877
Pubmed	TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes.	TBC1D1 VPS13A	2.60e-05	3	103	2	33087848
Pubmed	Regulation of the Fanconi anemia pathway by a SUMO-like delivery network.	ATAD5 WDR48	2.60e-05	3	103	2	21896657
Pubmed	The protease Omi regulates mitochondrial biogenesis through the GSK3β/PGC-1α pathway.	GSK3B PPARGC1A	2.60e-05	3	103	2	25118933
Pubmed	Recovery of muscle mass and muscle oxidative phenotype following disuse does not require GSK-3 inactivation.	GSK3B PPARGC1A	2.60e-05	3	103	2	32087280
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CYLD CACNB2 SHROOM3 ILF3 CORO1B CIT GSK3B UBE2O FAM120C LIMCH1 CNOT1 WNK2	2.88e-05	963	103	12	28671696
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CYLD CASP8AP2 SHROOM3 ILF3 ATAD5 SMPD4 DDOST CEMIP2 WDR19 VANGL2 PLEKHG1 UBE2O VPS13A MRPS11 PLEKHA1	3.23e-05	1487	103	15	33957083
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	ZNF280B PIAS4 RESF1 L3MBTL3 MYBL2	3.66e-05	125	103	5	32891193
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	CACNB2 PARD3B CEMIP2 CCNY VANGL2 NHSL1 PLEKHA7 WDR48	3.76e-05	421	103	8	36976175
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SHROOM3 RARS1 CORO1B CEMIP2 SNAP29 NHSL1 PLEKHA1 LIMCH1 PLEKHA7	4.79e-05	565	103	9	25468996
Pubmed	Association of SHMT1, MAZ, ERG, and L3MBTL3 Gene Polymorphisms with Susceptibility to Multiple Sclerosis.	ERG L3MBTL3	5.19e-05	4	103	2	30456721
Pubmed	DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1.	ERG GSK3B	5.19e-05	4	103	2	32871104
Pubmed	Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans.	DNAH10 RNASEL	5.19e-05	4	103	2	24891332
Pubmed	Requirement of argininosuccinate lyase for systemic nitric oxide production.	ASS1 NOS3	5.19e-05	4	103	2	22081021
Pubmed	Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice.	PPARGC1A NOS3	5.19e-05	4	103	2	24392081
Pubmed	Developmental changes and regional localization of Dspp, Mepe, Mimecan and Versican in postnatal developing mouse teeth.	MEPE VCAN	5.19e-05	4	103	2	22042093
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	SHROOM3 UBE2O RESF1 LIMCH1	6.05e-05	71	103	4	33541421
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CACNB2 ILF3 ACO2 CORO1B CIT GSK3B NHSL1 UBE2O FAM120C VCAN LIMCH1 PLEKHA7 CNOT1 WNK2	8.40e-05	1431	103	14	37142655
Pubmed	Inactivation of HDAC5 by SIK1 in AICAR-treated C2C12 myoblasts.	GSK3B PPARGC1A	8.64e-05	5	103	2	18946175
Pubmed	Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif.	PIAS4 PPARGC1A	8.64e-05	5	103	2	18063693
Pubmed	LAMP-2 is required for incorporating syntaxin-17 into autophagosomes and for their fusion with lysosomes.	VPS33A SNAP29	8.64e-05	5	103	2	27628032
Pubmed	Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.	TLR6 NOS3	8.64e-05	5	103	2	23477738
Pubmed	Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1.	ATAD5 WDR48	8.64e-05	5	103	2	20147293
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	PDS5B ILF3 RARS1 TNPO2 THOC2 CIT GSK3B KMT2C RESF1 L3MBTL3 CNOT1 MYBL2	1.05e-04	1103	103	12	34189442
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	CYLD VPS33A PLEKHG1 PLEKHA7 CNOT1 MYBL2	1.06e-04	251	103	6	29778605
Pubmed	Pax9 and Gbx2 Interact in the Pharyngeal Endoderm to Control Cardiovascular Development.	ERG PAX9	1.29e-04	6	103	2	32466118
Pubmed	Mitochondrial dysfunction precedes depression of AMPK/AKT signaling in insulin resistance induced by high glucose in primary cortical neurons.	GSK3B PPARGC1A	1.29e-04	6	103	2	26926143
Pubmed	Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4.	GSK3B PIAS4	1.29e-04	6	103	2	27162139
Pubmed	Promotion of RAD51-Mediated Homologous DNA Pairing by the RAD51AP1-UAF1 Complex.	ATAD5 WDR48	1.29e-04	6	103	2	27239033
Pubmed	SNP-by-fitness and SNP-by-BMI interactions from seven candidate genes and incident hypertension after 20 years of follow-up: the CARDIA Fitness Study.	PPARGC1A NOS3	1.29e-04	6	103	2	20944660
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	ILF3 SMPD4 CORO1B LRP1B SNAP29 VANGL2 CNOT1	1.31e-04	375	103	7	32788342
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CYLD ATAD5 SPAG9 THOC2 SNAP29 UBE2O ZNF592 L3MBTL3 CNOT1	1.31e-04	645	103	9	25281560
Pubmed	A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci.	PLEKHA1 UQCC1 IHH	1.41e-04	34	103	3	20189936
Pubmed	High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.	GC GSK3B MEPE TGFBR3 PPARGC1A PAX9 IHH	1.49e-04	383	103	7	19453261
Pubmed	Utility of incorporating genetic variants for the early detection of prostate cancer.	ERG RNASEL	1.81e-04	7	103	2	19223501
Pubmed	TREX is a conserved complex coupling transcription with messenger RNA export.	THOC3 THOC2	1.81e-04	7	103	2	11979277
Pubmed	Rab27a controls HIV-1 assembly by regulating plasma membrane levels of phosphatidylinositol 4,5-bisphosphate.	SYTL2 PI4K2A	1.81e-04	7	103	2	25940347
Pubmed	Shroom3 functions downstream of planar cell polarity to regulate myosin II distribution and cellular organization during neural tube closure.	SHROOM3 VANGL2	1.81e-04	7	103	2	25596276
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CYLD PDS5B PLEKHG1 TBC1D1 LIMCH1 CAMTA1 WDR48	2.16e-04	407	103	7	12693553
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RARS1 SPAG9 CORO1B THOC2 SNAP29 KMT2C UBE2O CNOT1	2.34e-04	549	103	8	38280479
Pubmed	Transcription factor ERG and joint and articular cartilage formation during mouse limb and spine skeletogenesis.	ERG IHH	2.40e-04	8	103	2	17336282
Pubmed	Genetic polymorphisms associated with priapism in sickle cell disease.	TGFBR3 NOS3	2.40e-04	8	103	2	17408468
Pubmed	Linking transcriptional elongation and messenger RNA export to metastatic breast cancers.	THOC3 THOC2	2.40e-04	8	103	2	15833825
Pubmed	Aly and THO are required for assembly of the human TREX complex and association of TREX components with the spliced mRNA.	THOC3 THOC2	2.40e-04	8	103	2	23222130
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	PDS5B CIT VPS13A CNOT1	2.47e-04	102	103	4	10231032
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SHROOM3 ERI2 KMT2C WDR48	2.56e-04	103	103	4	10819331
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	SMPD4 SPAG9 CORO1B CEMIP2 SNAP29 VPS13A PLEKHA1 LIMCH1	2.95e-04	568	103	8	37774976
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	PDS5B ATP8B4 ILF3 RARS1 DNAH10 POLA1 ACO2 THOC3 THOC2 DDOST UBE2O PLEKHA7 CNOT1	3.02e-04	1425	103	13	30948266
Pubmed	The THO complex regulates pluripotency gene mRNA export and controls embryonic stem cell self-renewal and somatic cell reprogramming.	THOC3 THOC2	3.08e-04	9	103	2	24315442
Pubmed	Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression.	SHROOM3 PPARGC1A	3.08e-04	9	103	2	10585775
Pubmed	Prickle1 stunts limb growth through alteration of cell polarity and gene expression.	VANGL2 IHH	3.08e-04	9	103	2	23913870
Pubmed	Plasticity within the niche ensures the maintenance of a Sox2+ stem cell population in the mouse incisor.	SOX11 VANGL2	3.08e-04	9	103	2	29180573
Pubmed	Msx1 haploinsufficiency modifies the Pax9-deficient cardiovascular phenotype.	ERG PAX9	3.08e-04	9	103	2	34615475
Pubmed	Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.	CASP8AP2 MUSK	3.08e-04	9	103	2	15883645
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	PDS5B ILF3 ACO2 SMPD4 THOC3 THOC2 DDOST VANGL2 VCAN MRPS11 CNOT1	3.69e-04	1082	103	11	38697112
Pubmed	Synovial joint formation during mouse limb skeletogenesis: roles of Indian hedgehog signaling.	ERG IHH	3.85e-04	10	103	2	18083924
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	ACO2 SMPD4 GSK3B KMT2C MEIOC CNOT1 BICC1	4.33e-04	457	103	7	32344865
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	PDS5B ATAD5 POLA1 THOC3 PIAS4 UBE2O ZNF592 MYBL2	4.62e-04	608	103	8	36089195
Pubmed	Identification of a candidate gene for astigmatism.	XYLT1 BICC1	4.69e-04	11	103	2	23322567
Pubmed	Pax9 is required for cardiovascular development and interacts with Tbx1 in the pharyngeal endoderm to control 4th pharyngeal arch artery morphogenesis.	ERG PAX9	4.69e-04	11	103	2	31444215
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	ILF3 ACO2 SMPD4 SPAG9 DDOST GSK3B SNAP29 VANGL2 AASS ASS1 VPS13A MRPS11 UQCC1	4.80e-04	1496	103	13	32877691
Pubmed	Tagging genes with cassette-exchange sites.	RARS1 TNPO2 CIT PHAF1 KMT2C RESF1	4.99e-04	335	103	6	15741177
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	PDS5B GSK3B PIAS4 RESF1 MYBL2	5.34e-04	222	103	5	37071664
Pubmed	Recruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replication.	THOC3 THOC2	5.62e-04	12	103	2	18974867
Pubmed	Role of GSK-3β in the osteogenic differentiation of palatal mesenchyme.	GSK3B IHH	5.62e-04	12	103	2	22022457
Pubmed	Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopment.	THOC3 THOC2	5.62e-04	12	103	2	38331934
Cytoband	4p14	TLR6 WDR19 TBC1D1	1.18e-04	42	103	3	4p14
Cytoband	Ensembl 112 genes in cytogenetic band chr4p14	TLR6 WDR19 TBC1D1	4.73e-04	67	103	3	chr4p14
Cytoband	12q24.31	CFAP251 DNAH10 VPS33A	7.95e-04	80	103	3	12q24.31
GeneFamily	THO complex	THOC3 THOC2	2.56e-04	7	64	2	770
Coexpression	AIZARANI_LIVER_C20_LSECS_3	ERG SPAG9 CEMIP2 PLEKHG1 TGFBR3 PIEZO2 LIMCH1 NOS3 SEC14L1	2.35e-06	295	102	9	M39121
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	SHROOM3 LRP1B PPARGC1A KMT2C LIMCH1 PCDH9 BICC1	4.88e-06	171	102	7	M39234
Coexpression	AIZARANI_LIVER_C9_LSECS_1	ERG CEMIP2 PLEKHG1 TGFBR3 PIEZO2 LIMCH1 NOS3 SEC14L1	2.55e-05	304	102	8	M39113
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	CACNB2 MASP1 ATAD5 POLA1 SYTL2 TGFBR3 PPARGC1A PIEZO2 RNASEL HMCN1 VCAN ASS1 PWWP3B PCDH9 BICC1	3.69e-06	773	101	15	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	SOX11 CASP8AP2 CACNB2 SHROOM3 ATAD5 ZNF280B SPAG9 ERI2 CEMIP2 VANGL2 XYLT1 PPARGC1A RNASEL NKAIN4 VPS13A PWWP3B CAMTA1 WNK2 MYBL2	2.17e-05	1370	101	19	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNB2 ABI3BP PARD3B PIEZO2 HMCN1 LIMCH1 ANO3 MUSK BICC1	6.60e-10	191	103	9	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNB2 ABI3BP PARD3B PIEZO2 HMCN1 LIMCH1 ANO3 MUSK BICC1	6.91e-10	192	103	9	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX11 DNAH10 LRP1B GMNC PPARGC1A PIEZO2 HMCN1 ANO3	1.15e-08	184	103	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX11 DNAH10 LRP1B GMNC PPARGC1A PIEZO2 HMCN1 ANO3	1.15e-08	184	103	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX11 DNAH10 LRP1B GMNC PPARGC1A PIEZO2 HMCN1 ANO3	1.15e-08	184	103	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	CACNB2 ABI3BP PIEZO2 HMCN1 LIMCH1 ANO3 MUSK BICC1	1.30e-08	187	103	8	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	ABI3BP XYLT1 TGFBR3 VCAN CYP4X1 CATSPERB MUSK BICC1	1.60e-08	192	103	8	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB2 ABI3BP PIEZO2 HMCN1 AASS LIMCH1 MUSK BICC1	1.66e-08	193	103	8	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB2 ABI3BP TGFBR3 PIEZO2 AASS LIMCH1 MUSK BICC1	1.73e-08	194	103	8	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	COPD-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	CACNB2 ABI3BP PIEZO2 HMCN1 AASS LIMCH1 MUSK BICC1	1.95e-08	197	103	8	d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 MASP1 ERG ABI3BP TGFBR3 HMCN1 VCAN ANO3	1.95e-08	197	103	8	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 RARS1 ABI3BP TGFBR3 HMCN1 BICC1 SEC14L1	2.81e-07	188	103	7	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 RARS1 ABI3BP TGFBR3 HMCN1 BICC1 SEC14L1	2.81e-07	188	103	7	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 RARS1 ABI3BP TGFBR3 HMCN1 BICC1 SEC14L1	2.81e-07	188	103	7	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 ABI3BP XYLT1 PIEZO2 VCAN CFAP69 BICC1	3.02e-07	190	103	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	CACNB2 ABI3BP PIEZO2 HMCN1 VCAN MUSK BICC1	3.02e-07	190	103	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB2 PARD3B PIEZO2 HMCN1 AASS LIMCH1 BICC1	3.35e-07	193	103	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNB2 ERG ABI3BP TGFBR3 HMCN1 LIMCH1 BICC1	3.35e-07	193	103	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	ABI3BP XYLT1 TGFBR3 VCAN CATSPERB MUSK BICC1	3.47e-07	194	103	7	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	CACNB2 ABI3BP PIEZO2 HMCN1 VCAN MUSK BICC1	3.47e-07	194	103	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	ABI3BP XYLT1 TGFBR3 VCAN CATSPERB MUSK BICC1	3.47e-07	194	103	7	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	SHROOM3 CFAP251 DNAH10 SAXO2 PARD3B LIMCH1 CFAP69	3.60e-07	195	103	7	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 PARD3B LRP1B PPARGC1A PLEKHA1 PLEKHA7 BICC1	3.60e-07	195	103	7	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNB2 ABI3BP PARD3B PIEZO2 HMCN1 LIMCH1 BICC1	3.60e-07	195	103	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	SHROOM3 CFAP251 DNAH10 SAXO2 PARD3B LIMCH1 CFAP69	3.60e-07	195	103	7	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNB2 ABI3BP PIEZO2 HMCN1 ANO3 MUSK BICC1	3.60e-07	195	103	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	CFAP251 ERG PLEKHG1 TGFBR3 PIEZO2 LIMCH1 SEC14L1	3.72e-07	196	103	7	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB2 ABI3BP TGFBR3 PIEZO2 HMCN1 AASS BICC1	3.72e-07	196	103	7	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNB2 ABI3BP PARD3B PIEZO2 HMCN1 MUSK BICC1	3.72e-07	196	103	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNB2 ABI3BP PIEZO2 HMCN1 VCAN CFAP69 BICC1	3.85e-07	197	103	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	CACNB2 ABI3BP PARD3B PIEZO2 HMCN1 VCAN BICC1	3.85e-07	197	103	7	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNB2 ABI3BP PARD3B LRP1B PIEZO2 VCAN BICC1	3.85e-07	197	103	7	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	background-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	MASP1 ABI3BP GC HMCN1 ASS1 PCDH9 ANO3	3.99e-07	198	103	7	79f32f965aed6a10c5cb803173e3db7b32e07a91
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNB2 ABI3BP PARD3B PIEZO2 HMCN1 MUSK BICC1	3.99e-07	198	103	7	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CACNB2 ABI3BP XYLT1 VCAN LIMCH1 CFAP69 BICC1	4.12e-07	199	103	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 ABI3BP TGFBR3 PIEZO2 HMCN1 VCAN BICC1	4.26e-07	200	103	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 ABI3BP TGFBR3 PIEZO2 HMCN1 VCAN BICC1	4.26e-07	200	103	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8\|TCGA-Thymus / Sample_Type by Project: Shred V9	ERG ABI3BP PIEZO2 HMCN1 CYP4X1 BICC1	1.41e-06	151	103	6	5906562efd36fbcb91f96e0a0d3a8fe999ba1e79
ToppCell	367C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	SPAG4 CFAP251 TGFBR3 PCDH9 NOS3 MYBL2	2.81e-06	170	103	6	fbb7019c6fba87326702b51f6819ea1af5f3a9b7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122\|Adult / Lineage, Cell type, age group and donor	SHROOM3 CIT AASS CYP4X1 LIMCH1 PCDH9	3.44e-06	176	103	6	3fee8a367bb9755aca1b7fcc968b08e51b6e9436
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	XYLT1 PLEKHG1 PPARGC1A AASS PLEKHA1 PCDH9	3.67e-06	178	103	6	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	ASK454-Epithelial-Ciliated\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	CFAP251 LRRIQ3 SAXO2 CORO1B CYP4X1 ANO3	3.79e-06	179	103	6	f21919ef9d3d984e2925ef3d24f89e20fe265dcd
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	ABI3BP TGFBR3 VCAN CATSPERB MUSK BICC1	3.79e-06	179	103	6	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CASP8AP2 SPAG4 ERG ABI3BP CEMIP2 VANGL2	3.91e-06	180	103	6	baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CASP8AP2 SPAG4 ERG ABI3BP CEMIP2 VANGL2	3.91e-06	180	103	6	2d608b9394d28d19cfc85c6ac94003d5177c8a92
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CASP8AP2 SPAG4 ERG ABI3BP CEMIP2 VANGL2	3.91e-06	180	103	6	0f9b27054358c4737eed06c8ea01987cccc3cb55
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 ABI3BP VCAN PLEKHA7 MUSK BICC1	4.04e-06	181	103	6	35eefd874a892eaf21f24fdce89e7ea3b8ee285f
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 ABI3BP VCAN PLEKHA7 MUSK BICC1	4.04e-06	181	103	6	e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB2 ABI3BP PIEZO2 HMCN1 MUSK BICC1	4.04e-06	181	103	6	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	SHROOM3 PARD3B PPARGC1A SH3RF2 CYP4X1 LIMCH1	4.44e-06	184	103	6	561592edc3083fad41b91811151b442207c65dd9
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	SHROOM3 CIT PLEKHG1 AASS LIMCH1 PCDH9	4.58e-06	185	103	6	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNB2 ABI3BP PARD3B TGFBR3 CFAP69 BICC1	4.58e-06	185	103	6	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CFAP251 SYTL2 ZNF280B TGFBR3 PCDH9 BICC1	4.72e-06	186	103	6	facc1bd8920003ad03d1893c32fc606d82b4d50a
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MASP1 PARD3B NHSL1 NKAIN4 AASS PLEKHA7	4.72e-06	186	103	6	41e03be964044dae690d566bd078dab3d8045eba
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	ERG CEMIP2 PLEKHG1 HMCN1 PWWP3B NOS3	4.87e-06	187	103	6	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	SHROOM3 FAT2 CYP4X1 PAX9 PLEKHA7 WNK2	5.17e-06	189	103	6	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	ERG CEMIP2 PLEKHG1 HMCN1 VCAN NOS3	5.17e-06	189	103	6	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CACNB2 ABI3BP NKAIN4 HMCN1 VCAN LIMCH1	5.33e-06	190	103	6	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERG PLEKHG1 PIEZO2 SHC2 HMCN1 CATSPERB	5.33e-06	190	103	6	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LRP1B TGFBR3 NKAIN4 VCAN LIMCH1 PCDH9	5.33e-06	190	103	6	7986586b7c82e91c71102cc8c4d7a689ae63ab4d
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ABI3BP ERI2 TGFBR3 CATSPERB MUSK BICC1	5.33e-06	190	103	6	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 ABI3BP PIEZO2 VCAN LIMCH1 BICC1	5.50e-06	191	103	6	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ABI3BP LRP1B PIEZO2 LIMCH1 PCDH9 BICC1	5.50e-06	191	103	6	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ABI3BP TGFBR3 VCAN CATSPERB MUSK BICC1	5.50e-06	191	103	6	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ABI3BP TGFBR3 CYP4X1 CATSPERB MUSK BICC1	5.50e-06	191	103	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG LRP1B TGFBR3 HMCN1 LIMCH1 NOS3	5.66e-06	192	103	6	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 ABI3BP PIEZO2 LIMCH1 CFAP69 BICC1	5.66e-06	192	103	6	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 ABI3BP XYLT1 PIEZO2 CFAP69 BICC1	5.66e-06	192	103	6	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 ABI3BP XYLT1 PIEZO2 CFAP69 BICC1	5.66e-06	192	103	6	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	LA\|World / Chamber and Cluster_Paper	ABI3BP LRP1B XYLT1 TGFBR3 VCAN BICC1	5.83e-06	193	103	6	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	ABI3BP TGFBR3 VCAN CATSPERB MUSK BICC1	5.83e-06	193	103	6	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNB2 ABI3BP TGFBR3 AASS CATSPERB BICC1	5.83e-06	193	103	6	261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22\|World / Primary Cells by Cluster	SOX11 MASP1 DNAH10 NHSL1 VCAN LIMCH1	5.83e-06	193	103	6	3b927d4b8ecb21a408424ef91a23746c21741f49
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	ERG CEMIP2 PLEKHG1 HMCN1 PWWP3B NOS3	6.01e-06	194	103	6	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 PARD3B PPARGC1A PLEKHA1 PLEKHA7 BICC1	6.01e-06	194	103	6	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	PND07-28-samps-Mesenchymal\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ABI3BP TGFBR3 NKAIN4 HMCN1 VCAN LIMCH1	6.01e-06	194	103	6	68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 ABI3BP PIEZO2 LIMCH1 CFAP69 BICC1	6.01e-06	194	103	6	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	ABI3BP PARD3B TGFBR3 VCAN CATSPERB BICC1	6.01e-06	194	103	6	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	Control-Stromal-Myofibroblast\|Control / Disease state, Lineage and Cell class	CACNB2 ABI3BP HMCN1 AASS LIMCH1 BICC1	6.19e-06	195	103	6	ffcf76cd72e43d8cf1058a49c76e0956065038bc
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNB2 ABI3BP PIEZO2 HMCN1 LIMCH1 MUSK	6.19e-06	195	103	6	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ATP8B4 ERG ATAD5 CIT PCDH9 MYBL2	6.19e-06	195	103	6	751cb00b0f3005be6b645adadfbb9dd2215b6e08
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	CACNB2 ABI3BP PIEZO2 HMCN1 MUSK BICC1	6.19e-06	195	103	6	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNB2 ABI3BP PIEZO2 HMCN1 LIMCH1 MUSK	6.19e-06	195	103	6	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ABI3BP TGFBR3 VCAN CATSPERB MUSK BICC1	6.19e-06	195	103	6	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 MASP1 TGFBR3 PIEZO2 HMCN1 BICC1	6.19e-06	195	103	6	f5e91ce20a7ce528dc4c1a968c7bf096bf45c528
ToppCell	COPD-Stromal-Myofibroblast\|COPD / Disease state, Lineage and Cell class	CACNB2 ABI3BP HMCN1 AASS LIMCH1 BICC1	6.37e-06	196	103	6	af206bb5bbb8b604a6212acd79878bcc3d326cec
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CACNB2 ATAD5 CIT PIEZO2 BICC1 MYBL2	6.37e-06	196	103	6	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNB2 ABI3BP PARD3B PIEZO2 VCAN BICC1	6.37e-06	196	103	6	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	SHROOM3 CFAP251 DNAH10 SAXO2 LIMCH1 CFAP69	6.37e-06	196	103	6	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ABI3BP PARD3B VCAN CATSPERB ANO3 BICC1	6.37e-06	196	103	6	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	ERG LRP1B PLEKHG1 TGFBR3 SHC2 SEC14L1	6.37e-06	196	103	6	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 ERG ABI3BP TGFBR3 HMCN1 BICC1	6.56e-06	197	103	6	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNB2 ABI3BP PARD3B LRP1B PIEZO2 VCAN	6.56e-06	197	103	6	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNB2 ABI3BP PIEZO2 HMCN1 VCAN BICC1	6.75e-06	198	103	6	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	CACNB2 ABI3BP TGFBR3 PIEZO2 HMCN1 BICC1	6.75e-06	198	103	6	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CACNB2 ABI3BP PIEZO2 HMCN1 VCAN BICC1	6.75e-06	198	103	6	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNB2 ABI3BP PIEZO2 HMCN1 VCAN BICC1	6.75e-06	198	103	6	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABI3BP PIEZO2 HMCN1 AASS LIMCH1 MUSK	6.75e-06	198	103	6	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	distal-mesenchymal-Alveolar_Fibroblast-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ABI3BP PIEZO2 HMCN1 AASS LIMCH1 MUSK	6.95e-06	199	103	6	28c1722deef3b8347371c7359be7c64b95780de3
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP SYTL2 TGFBR3 VCAN LIMCH1 BICC1	6.95e-06	199	103	6	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
Drug	2-methylaspartate	CIT ASS1 NOS3	3.11e-06	7	103	3	CID000002109
Disease	neuroimaging measurement	SOX11 CACNB2 SHROOM3 VANGL2 GMNC NHSL1 PLEKHG1 PPARGC1A VCAN UQCC1 CAMTA1 PLEKHA7 L3MBTL3 MUSK WNK2	4.04e-06	1069	102	15	EFO_0004346
Disease	mean fractional anisotropy measurement	VANGL2 PPARGC1A VCAN CAMTA1 WNK2	2.02e-05	95	102	5	EFO_0008399
Disease	diastolic blood pressure, alcohol drinking	CACNB2 SAXO2 PLEKHG1 PLEKHA7 NOS3	5.74e-05	118	102	5	EFO_0004329, EFO_0006336
Disease	pulmonary venoocclusive disease (is_marker_for)	ERG EIF2AK4	7.07e-05	4	102	2	DOID:5453 (is_marker_for)
Disease	response to non-steroidal anti-inflammatory, drug-induced liver injury	SYTL2 CAMTA1	7.07e-05	4	102	2	EFO_0004228, EFO_0005533
Disease	brain connectivity measurement	SOX11 GMNC PIAS4 NHSL1 PLEKHG1 VCAN UQCC1 WNK2	7.69e-05	400	102	8	EFO_0005210
Disease	pulse pressure measurement	CACNB2 SHROOM3 ATP8B4 ERG PLEKHG1 TGFBR3 PPARGC1A PIEZO2 UQCC1 EIF2AK4 PLEKHA7 CFAP69 CNOT1 MUSK BICC1	8.69e-05	1392	102	15	EFO_0005763
Disease	cortical thickness	PDS5B SOX11 SHROOM3 VANGL2 GMNC NHSL1 PLEKHG1 VCAN UQCC1 CAMTA1 PLEKHA7 MUSK WNK2	1.22e-04	1113	102	13	EFO_0004840
Disease	ascending aortic diameter	CACNB2 MASP1 ATAD5 PIEZO2 HMCN1	1.29e-04	140	102	5	EFO_0021787
Disease	citrate measurement	SHROOM3 CNOT1 MUSK WNK2	1.66e-04	79	102	4	EFO_0010114
Disease	level of Phosphatidylcholine (18:2_0:0) in blood serum	PARD3B MUSK	1.76e-04	6	102	2	OBA_2045105
Disease	pulmonary venoocclusive disease (biomarker_via_orthology)	ERG EIF2AK4	2.46e-04	7	102	2	DOID:5453 (biomarker_via_orthology)
Disease	retinopathy of prematurity (is_implicated_in)	IHH NOS3	2.46e-04	7	102	2	DOID:13025 (is_implicated_in)
Disease	heart disease (implicated_via_orthology)	GSK3B PPARGC1A CNOT1	3.10e-04	38	102	3	DOID:114 (implicated_via_orthology)
Disease	lean body mass	ATAD5 KIZ PARD3B VCAN PLEKHA1 L3MBTL3 NOS3	3.54e-04	379	102	7	EFO_0004995
Disease	S-warfarin measurement	LRP1B NHSL1 TBC1D1 EIF2AK4	3.64e-04	97	102	4	EFO_0803323
Disease	neuroimaging measurement, brain volume measurement	CACNB2 GMNC PPARGC1A VCAN CATSPERB WNK2	4.86e-04	286	102	6	EFO_0004346, EFO_0006930
Disease	cortical thickness, neuroimaging measurement	GMNC VCAN UQCC1 MUSK	5.87e-04	110	102	4	EFO_0004346, EFO_0004840
Disease	white matter hyperintensity measurement	CACNB2 PLEKHG1 VCAN CATSPERB LIMCH1 NOS3	6.47e-04	302	102	6	EFO_0005665
Disease	R-6-hydroxywarfarin measurement	SHROOM3 ERG LRP1B PCDH9	6.71e-04	114	102	4	EFO_0803327
Disease	mean platelet volume	PDS5B CFAP251 ATP8B4 PCDHGC5 ATAD5 POLA1 MEIOC CATSPERB CAMTA1 NOS3 MUSK	8.08e-04	1020	102	11	EFO_0004584
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	DNAH10 GC TBC1D1 L3MBTL3 MUSK	1.02e-03	220	102	5	EFO_0004529, EFO_0008317
Disease	systolic blood pressure, alcohol drinking	CACNB2 PLEKHG1 PLEKHA7 NOS3	1.03e-03	128	102	4	EFO_0004329, EFO_0006335
Disease	cardiovascular disease	CACNB2 MEPE PLEKHG1 NKAIN4 TBC1D1 NOS3 BICC1	1.07e-03	457	102	7	EFO_0000319
Disease	Agents acting on the renin-angiotensin system use measurement	CACNB2 PLEKHG1 TBC1D1 ANO3 NOS3 BICC1	1.11e-03	335	102	6	EFO_0009931
Disease	platelet component distribution width	PDS5B GSK3B UBE2O MEIOC CATSPERB EIF2AK4 CAMTA1 NOS3 MUSK	1.24e-03	755	102	9	EFO_0007984
Disease	osteoarthritis, hip, osteoarthritis, knee	ERG TGFBR3 UQCC1	1.31e-03	62	102	3	EFO_0004616, EFO_1000786
Disease	Diabetic Angiopathies	ASS1 NOS3	1.38e-03	16	102	2	C0011875
Disease	Microangiopathy, Diabetic	ASS1 NOS3	1.38e-03	16	102	2	C0025945
Disease	Huntington's disease (biomarker_via_orthology)	PPARGC1A NOS3	1.38e-03	16	102	2	DOID:12858 (biomarker_via_orthology)
Disease	diabetic retinopathy (implicated_via_orthology)	PPARGC1A NOS3	1.38e-03	16	102	2	DOID:8947 (implicated_via_orthology)
Disease	bipolar I disorder	CACNB2 ILF3 ZNF592 MUSK	1.48e-03	141	102	4	EFO_0009963
Disease	response to radiation, Urinary retention	LRP1B CAMTA1	1.56e-03	17	102	2	GO_0009314, HP_0000016
Disease	laryngeal squamous cell carcinoma	VCAN MUSK	1.56e-03	17	102	2	EFO_0006352
Disease	copine-1 measurement	SPAG4 UQCC1	1.56e-03	17	102	2	EFO_0008102
Disease	spine bone size	UQCC1 MUSK	1.75e-03	18	102	2	EFO_0004508
Disease	hemifacial microsomia	SHROOM3 PARD3B	1.95e-03	19	102	2	MONDO_0015398
Disease	glaucoma	LRP1B WDR19 PLEKHA7 BICC1	2.04e-03	154	102	4	MONDO_0005041
Disease	number of teeth measurement	CACNB2 PAX9	2.16e-03	20	102	2	EFO_0010073
Disease	stem Cell Growth Factor beta measurement	PIEZO2 PLEKHA7 PCDH9	2.26e-03	75	102	3	EFO_0008292
Disease	Antihypertensive use measurement	CACNB2 PLEKHG1 PLEKHA1 NOS3 BICC1	2.31e-03	265	102	5	EFO_0009927
Disease	cortical surface area measurement	SOX11 SHROOM3 PARD3B SNAP29 VANGL2 GMNC NHSL1 PLEKHG1 VCAN PLEKHA7 L3MBTL3 WNK2	2.35e-03	1345	102	12	EFO_0010736
Disease	white matter microstructure measurement	CACNB2 GMNC PLEKHG1 VCAN CATSPERB UQCC1	2.38e-03	390	102	6	EFO_0005674
Disease	Moderate albuminuria	SHROOM3 CAMTA1 PLEKHA7	2.72e-03	80	102	3	HP_0012594
Disease	Diuretic use measurement	CACNB2 PLEKHG1 NOS3 BICC1	2.85e-03	169	102	4	EFO_0009928
Disease	level of Sphingomyelin (d40:2) in blood serum	GC MUSK	2.86e-03	23	102	2	OBA_2045181
Disease	sciatic neuropathy (implicated_via_orthology)	GSK3B PPARGC1A	2.86e-03	23	102	2	DOID:11446 (implicated_via_orthology)
Disease	phosphatidylserines measurement	CFAP69 MUSK	2.86e-03	23	102	2	EFO_0020049
Disease	sensory perception of sweet taste	XYLT1 ANO3 WNK2	2.91e-03	82	102	3	GO_0050916
Disease	brain measurement, neuroimaging measurement	CACNB2 VANGL2 GMNC NHSL1 VCAN CATSPERB WNK2	3.03e-03	550	102	7	EFO_0004346, EFO_0004464
Disease	carotid plaque build	ABI3BP TGFBR3 MUSK	3.12e-03	84	102	3	EFO_0006501
Disease	thalamus volume	GMNC PPARGC1A CAMTA1	3.23e-03	85	102	3	EFO_0006935

Protein segments in the cluster

Peptide	Gene	Start	Entry
HDFPVYNPALLNLPK	VANGL2	281	Q9ULK5
PAAFPKDNIHFKPIN	ZNF280B	236	Q86YH2
PLTFADPADYNKIHP	ACO2	706	Q99798
ALPPKTLANYFKVSP	ATAD5	1231	Q96QE3
PSIYNKEPKNIINPH	ERI2	276	A8K979
PAPKKHKLNPEYFQT	CAMTA1	1241	Q9Y6Y1
LTDNFYHADPSKPIP	CATSPERB	881	Q9H7T0
QPPASTKFHPDINVY	VCAN	1311	P13611
QSFLSEHNKPPPKSF	EIF2AK4	131	Q9P2K8
AQALQPHPPESSLYK	ERG	396	P11308
LPAPEHSNNPLRYKF	AASS	636	Q9UDR5
PPYIHFLNTFTSKEP	CORO1B	301	Q9BR76
KNPPPTSGLEKTHYN	ATP8B4	1151	Q8TF62
PLSKSEVPPDYDKHN	CCNY	151	Q8ND76
QSLKTQPTPYCKPDH	C7orf31	446	Q8N865
PDPSNPQKKSTVYLQ	BICC1	321	Q9H694
PPQVPVYNNSHKDVF	CASP8AP2	876	Q9UKL3
PNKRGPPTYNEHITK	CIT	1921	O14578
LYTKTQDPAKAPNTP	ASS1	206	P00966
FKKTEHTPPYDVVPS	CACNB2	266	Q08289
PPHEGAYKSSQPIKT	ANO3	341	Q9BYT9
NLPDFLKVYLNHKPP	CFAP251	1026	Q8TBY9
PDKNFSNTKNYLPPE	PDS5B	1101	Q9NTI5
EPPVNLKYNAPTSHV	SPAG9	571	O60271
VPAKLFKEHQSFPYN	L3MBTL3	246	Q96JM7
AKVNKPYHPLVPADS	PARD3B	1001	Q8TEW8
DSYKQHQPTPQPALP	PAX9	141	P55771
PAQSFHKELFTKQPP	KMT2C	1821	Q8NEZ4
FKLPHTAPPIYLNSD	LRP1B	4531	Q9NZR2
YTNLTQEKPPPAQAK	MAP10	306	Q9P2G4
HQGKVEFHYPPAPSK	MEPE	366	Q9NQ76
PRFNDYKANDHKPLP	GRXCR2	101	A6NFK2
SLKPEQVYSSPNKQP	MSS51	416	Q4VC12
TPVAPQYHLKPSAFL	NHSL1	1106	Q5SYE7
EDVNDNPPKFKHLPY	FAT2	2061	Q9NYQ8
PDLPFQIKPSENHYS	PCDHGC5	391	Q9Y5F6
YQHPKSPLSTFAPQK	PCDH9	1151	Q9HC56
EHKSPQPTKNFSIPD	KIZ	176	Q2M2Z5
PDKPITQYPHAVGKN	DDOST	226	P39656
KDPQDYPDKKSLPHV	POLA1	1141	P09884
LPDSPLYHNKVQFTP	SMPD4	166	Q9NXE4
SAKKYFNLNVHVPPS	HMCN1	2951	Q96RW7
PYNSSPRPEQHKSYK	NOS3	596	P29474
LKYLTTNDDPPHTKP	PPARGC1A	211	Q9UBK2
FKPKNEEPYGHLNPK	PI4K2A	151	Q9BTU6
HYDPPFNISKLLTPI	CEFIP	436	Q711Q0
TDPKSQYLQKFSPPL	CYP4X1	106	Q8N118
FSHQVPQKVKYPPPF	FAM120C	446	Q9NX05
NYNSPVPPKHAGKKQ	ILF3	721	Q12906
PNYTEFKFPQIKAHP	GSK3B	286	P49841
PHKSYLPVQFQSPDK	CEMIP2	1206	Q9UHN6
PPVHGKIEPSQAKYF	MASP1	306	P48740
LNHKYNPVSLPKDLP	CYLD	831	Q9NQC7
PPKKHIPGYQQASSS	CFAP69	171	A5D8W1
YKNIVQDLPPTPSKF	DNAH10	2636	Q8IVF4
QDLPPTPSKFHYIFN	DNAH10	2641	Q8IVF4
VFNIYHSKRSPQPPK	SEC14L1	561	Q92503
PLAYKQFSPNVPEKT	IHH	46	Q14623
LTPKPYSQPKNSQDV	LIMCH1	536	Q9UPQ0
EFQSDPKPSQYRKPS	SYTL2	376	Q9HCH5
PKPSQYRKPSLFHQS	SYTL2	381	Q9HCH5
HLQDKFPDYLTVSPP	RARS1	251	P54136
KQQFAKPDPPHSEYF	MEIOC	441	A2RUB1
KPDPPHSEYFKSVNL	MEIOC	446	A2RUB1
LYYSFKNITKQHPPP	SOX11	311	P35716
KEQRYSPAEIPHPKN	GMNC	151	A6NCL1
VPQKQSDSPPHKKYR	PWWP3B	121	Q5H9M0
YPKSQPPFLHQSLIN	RESF1	16	Q9HCM1
PHTPTPFKNALEKYG	MYBL2	516	P10244
FPENYQTLPKSTRHP	PLEKHA7	466	Q6IQ23
EYRKHFPQTHSPNKP	RNASEL	711	Q05823
NYFKSKPVETPPEQN	SNAP29	121	O95721
ENSPPVKPKHNYTQK	SHROOM3	441	Q8TF72
YRHPVSVKKIFPDPN	WDR19	511	Q8NEZ3
PSPHKQVPSKCNDYF	PHAF1	271	Q9BSU1
FHLQNDPPAAFPKVK	SPAG4	386	Q9NPE6
DNPLHYQKSLKPAPH	CNOT1	96	A5YKK6
PFPLYHVNEKPSSLL	NKAIN4	186	Q8IVV8
QNAAPSHTKFSIYPP	MRPS11	51	P82912
STAEFTHYKPPLNLP	XYLT1	801	Q86Y38
HPPNYKKPVLFSFQP	VPS13A	2236	Q96RL7
AKLYINHTPPPLSKS	THOC2	1436	Q8NI27
KFNKIPFYLQPHASS	WDR48	561	Q8TAF3
RFKQYLHSPPKVALP	SHC2	301	P98077
NPKLTDGYPAFKRPH	TEX37	61	Q96LM6
KNNVKAHYQSFPPPV	TNPO2	71	O14787
NKVLHSSNPVPLYAP	ZNF592	556	Q92610
HQFPSKQQPKDVPYK	TBC1D1	821	Q86TI0
YPELKPVQSINAHPS	THOC3	211	Q96J01
KNVEVNKDKPYHPPN	PIEZO2	1991	Q9H5I5
PSNHSFKKIEFQPPE	UBE2O	936	Q9C0C9
LKHQPQEFPTYVEPT	GC	126	P02774
KNPQSILKPHSPTYN	UQCC1	281	Q9NVA1
KSATYRQHAQPPKPS	TBCK	706	Q8TEA7
YAKKNSEPAPQPHRP	PIAS4	66	Q8N2W9
ELYKPEQTYHPPTVK	SAXO2	96	Q658L1
LEPIPQNSIPNKYHK	TLR6	736	Q9Y2C9
QPKETQPFPKSEQVY	ZNF232	171	Q9UNY5
KTVRFQNYSPPPTKH	SH3RF2	641	Q8TEC5
PKEPLSFSVFHYKNP	PLEKHG1	376	Q9ULL1
IQNSYVKLPPEKFAP	VPS33A	256	Q96AX1
QVPPPSKFSLHYLRK	TBCCD1	21	Q9NVR7
QSKQPPDSAPYKDQL	WNK2	1376	Q9Y3S1
PNTSYEFQVKPKNPL	ABI3BP	896	Q7Z7G0
QSHLPYFTPKPPQDS	PLEKHA1	176	Q9HB21
PPPKESFSKFHQQRQ	XIRP1	36	Q702N8
VKFYSPKRVHFPIPQ	TGFBR3	666	Q03167
REKKQHFFPAYPQPI	LRRIQ3	371	A6PVS8
PHLDYNKENLKTFPP	MUSK	451	O15146